Home182400 • KOSDAQ
add
NKGen Biotech Korea Co ltd
Previous close
₩3,670.00
Year range
₩8,621.25 - ₩9,903.75
Market cap
172.75B KRW
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 2.21B | -0.77% |
Operating expense | 4.57B | 139.92% |
Net income | -782.85M | -115.51% |
Net profit margin | -35.41 | -115.63% |
Earnings per share | — | — |
EBITDA | -2.84B | -1,573.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.76B | -63.20% |
Total assets | 14.29B | -37.52% |
Total liabilities | 7.20B | -84.97% |
Total equity | 7.10B | — |
Shares outstanding | 71.09M | — |
Price to book | 36.77 | — |
Return on assets | -51.84% | — |
Return on capital | -68.59% | — |
Cash Flow
Net change in cash
| (KRW) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -782.85M | -115.51% |
Cash from operations | -1.27B | -224.42% |
Cash from investing | 3.17B | 200.95% |
Cash from financing | -1.43B | -172.14% |
Net change in cash | 497.12M | 268.29% |
Free cash flow | -4.29B | -142.89% |
About
Founded
2002
Website
Employees
72
